Atlas Trials

Shen Feng

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shen Feng

RecordFirmDate
A Machine Learning Architecture to Predict Post-Hepatectomy Liver Failure Using Liver Regeneration Biomarkers and Time-Phased Data (NCT05779098)Shen Feng2023-04-01
Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC (NCT05781958)Shen Feng2022-11-24
Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid (NCT06699524)Shen Feng2022-09-20
Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With Anlotinib (NCT05453383)Shen Feng2022-07-08

Track Shen Feng automatically

Every clearance here is in the API, with alerts when new ones post.